These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 12387009

  • 1. [Application and practice of intensive insulin therapy].
    Kishikawa H, Soejima H, Tamama Y, Araki E, Shichiri M.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of insulin delivery devices in diabetes care.
    Garg SK.
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract] [Full Text] [Related]

  • 5. [Continuous subcutaneous insulin infusion].
    Ito H, Kanatsuka A.
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract] [Full Text] [Related]

  • 6. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P.
    Wiad Lek; 2004 Nov; 57(5-6):263-6. PubMed ID: 15518073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Intensive insulin therapy].
    Landgraf R, Huber RM, Bachmann A, Lohr R.
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract] [Full Text] [Related]

  • 9. [Risks and side effects of intensified insulin therapy].
    Honegger R, Spinas GA.
    Wien Med Wochenschr; 1997 Apr; 147(9):226-30. PubMed ID: 9281237
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C.
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [Abstract] [Full Text] [Related]

  • 12. The importance of titrating starting insulin regimens in patients with type 2 diabetes.
    Garber AJ.
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():10-3. PubMed ID: 19817778
    [No Abstract] [Full Text] [Related]

  • 13. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ.
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [Abstract] [Full Text] [Related]

  • 14. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
    Currie CJ, Johnson JA.
    Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overcoming barriers to insulin replacement.
    Kuritzky L.
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M, Ruxer J, Loba J.
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [Abstract] [Full Text] [Related]

  • 19. [New methods in insulin treatment].
    Neuwirth G.
    Orv Hetil; 2005 Jan 16; 146(3):111-6. PubMed ID: 15693442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.